- Home
- WIA vs CYBN Comparison
WIA vs CYBN Comparison
Compare WIA & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- CYBN
- Stock Information
- Founded
- WIA 2003
- CYBN 2019
- Country
- WIA United States
- CYBN Canada
- Employees
- WIA N/A
- CYBN N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- CYBN Pharmaceuticals and Biotechnology
- Sector
- WIA Finance
- CYBN Health Care
- Exchange
- WIA Nasdaq
- CYBN Nasdaq
- Market Cap
- WIA 192.9M
- CYBN 180.4M
- IPO Year
- WIA N/A
- CYBN N/A
- Fundamental
- Price
- WIA $8.37
- CYBN $8.23
- Analyst Decision
- WIA
- CYBN Strong Buy
- Analyst Count
- WIA 0
- CYBN 4
- Target Price
- WIA N/A
- CYBN $85.00
- AVG Volume (30 Days)
- WIA 39.2K
- CYBN 438.5K
- Earning Date
- WIA 01-01-0001
- CYBN 08-07-2025
- Dividend Yield
- WIA 12.29%
- CYBN N/A
- EPS Growth
- WIA N/A
- CYBN N/A
- EPS
- WIA N/A
- CYBN N/A
- Revenue
- WIA N/A
- CYBN N/A
- Revenue This Year
- WIA N/A
- CYBN N/A
- Revenue Next Year
- WIA N/A
- CYBN N/A
- P/E Ratio
- WIA N/A
- CYBN N/A
- Revenue Growth
- WIA N/A
- CYBN N/A
- 52 Week Low
- WIA $7.56
- CYBN $4.81
- 52 Week High
- WIA $8.91
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- WIA 58.40
- CYBN 55.46
- Support Level
- WIA $8.30
- CYBN $7.31
- Resistance Level
- WIA $8.41
- CYBN $7.85
- Average True Range (ATR)
- WIA 0.05
- CYBN 0.55
- MACD
- WIA -0.01
- CYBN 0.02
- Stochastic Oscillator
- WIA 48.75
- CYBN 41.18
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.